SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026)
SS Innovations International (SSII) reported Cash from Investing Activities of -$54189.0 for Q1 2026, up 93.79% on a YoY basis from -$27962.5 in Q1 2025, and up 96.84% sequentially from -$1.7 million in Q4 2025.
SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026) Analysis & Trends
SS Innovations International (SSII) has 10 years of Cash from Investing Activities data on file, last reported at -$54189.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 93.79% year-over-year to -$54189.0; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (down 101.88% YoY), and the FY2025 full-year result was -$3.7 million, down 453.16% from the prior year.
- Cash from Investing Activities grew to -$54189.0 in Q1 2026, from -$1.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q3 2024 to a low of -$2.1 million in Q2 2024.
- A 5-year average of -$331267.5 and a median of -$127255.0 in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities sank 6329.8% in 2023 and jumped 872.1% in 2024, its largest moves.
- Tracing SSII's Cash from Investing Activities over 5 years: stood at -$137530.0 in 2022, then increased by 7.48% to -$127249.0 in 2023, then advanced by 1.66% to -$125142.0 in 2024, then sank by 1270.07% to -$1.7 million in 2025, then soared by 96.84% to -$54189.0 in 2026.
- Business Quant data shows SSII's Cash from Investing Activities at -$54189.0 in Q1 2026, -$1.7 million in Q4 2025, and -$755075.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn | -54,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54,189.00 |
| Mar 31, 2026 | -54,189.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -755,075.00 |
| Sep 30, 2025 | -755,075.00 |
| Jun 30, 2025 | -316,648.00 |
| Jun 30, 2025 | -316,648.00 |
| Mar 31, 2025 | -872,804.00 |
| Mar 31, 2025 | -872,804.00 |
| Dec 31, 2024 | -125,142.00 |
| Dec 31, 2024 | -125,142.00 |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -127,255.00 |
| Mar 31, 2024 | -127,255.00 |
| Dec 31, 2023 | -127,249.00 |
| Dec 31, 2023 | -127,249.00 |